World

Controversial vaccine trial touted by RFK Jr gets go-ahead in Guinea-Bissau

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 14/10/2026, 12:23:29 UTC.

Briefings

A controversial research trial to withhold hepatitis B vaccines from newborns in Guinea-Bissau received ethics committee approval, aligning with Robert F Kennedy Jr.'s vaccine opposition. The trial involves thousands of newborns and was amended on October 13, 2026, with earlier reports citing CIDRAP before Rolling Stone.

Key points

• The trial involves withholding hepatitis B vaccines from thousands of newborns in Guinea-Bissau.
• The trial received ethics committee approval and was amended on October 13, 2026.

Context

This trial aligns with Robert F Kennedy Jr.'s vaccine opposition and is part of his broader vaccine vision. The article notes that Rolling Stone reported the news first, while the article itself cites CIDRAP.

Limitations

The evidence is limited to the article's content, which states the trial received approval and was amended on October 13, 2026. It does not specify the exact number of newborns, the specific ethical criteria, or the long-term outcomes of the trial.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 19/10/2026, 01:00:20 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeibgygq6xobnz453c3n7akqfk2zrhofwknljte2pmrzp6k5dgj6pjq